Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity
- 1 September 2003
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 170 (1), 177-180
- https://doi.org/10.1016/s0021-9150(03)00281-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid ArthritisCirculation, 2002
- Impaired Responsiveness to NO in Newly Diagnosed Patients With Rheumatoid ArthritisArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Tumor Necrosis Factor Antagonism With Etanercept Improves Systemic Endothelial Vasoreactivity in Patients With Advanced Heart FailureCirculation, 2001
- Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidityThe Lancet, 2000
- Proinflammatory Mediators Chronically Downregulate the Formation of the Endothelium-Derived Hyperpolarizing Factor in Arteries Via a Nitric Oxide/Cyclic GMP–Dependent MechanismCirculation, 1999
- Clinical Pharmacokinetics of Low-Dose Pulse Methotrexate in Rheumatoid ArthritisClinical Pharmacokinetics, 1996
- Measuring Forearm Blood Flow and Interpreting the Responses to Drugs and MediatorsHypertension, 1995
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.Circulation Research, 1993